Contact Information:
Office Location: Gateway C
Email: ting-yuan.cheng@osumc.edu
Department: Medicine – IM Cancer Prevention and Control
I am an Associate Professor in the Division of Cancer Prevention and Control at The Ohio State University and a member of the Cancer Control Program at the OSUCCC – James. My laboratory has been devoted to understanding cancer etiology and factors that affect cancer outcomes in different racial and ethnic populations.
My main research areas are (1) molecular pathological epidemiology in obesity-related cancers and lung cancer; (2) gene-environmental interaction in nutrition-related pathways; (3) cancer health disparities in relation to race/ethnicity and sex. I lead NIH/NCI projects aiming to understand the mammalian target of rapamycin (mTOR) as a molecular mechanism of how energy imbalance influences the etiology and outcomes of breast cancer. The goal is to find out to what extent the mTOR pathway can be modified by weight reduction, physical activity, and mTOR inhibitors to improve breast cancer prognosis.
I have a strong record of research collaboration with large, national-level studies, including the Women’s Health Initiative, the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium, and the Pathways Study. I serve as an Editorial Board member of the JNCI: Journal of the National Cancer Institute.
My page at the James, OSUCCC: David Cheng, PhD, MHS, MS, BS | Ohio State cancer researcher (osu.edu)